Immunomodulators and Biologics in Dermatologic Treatment

Turning Theory into Practice
2024
ISBN: 978-3-031-66589-9
Verlag: Springer

Buch, Englisch, 184 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 494 g

This title provides a practically applicable guide to the use of immunomodulators and biologics to treat cutaneous diseases. Chapters cover the mechanisms, applications and safety concerns pertaining to the latest systemic therapies. Extensive guidance is provided on how to design lab monitoring schedules, manage patient follow-up visits, develop tapering plans and assess adverse outcomes. The book also reviews how to initiate off-label applications and establish methods of matching mechanisms for a range of diseases to the mechanisms of the available therapies. The latest updates in the development and utility of systemic immunomodulators, biologics and JAK Inhibitors from clinical trials and updated guidelines are also discussed.

comprehensively describes the use of a range of systemic therapies for immunomodulation in dermatology and how best to incorporate these into practice. It therefore represents a valuable resource for novice readers and experienced dermatologists involved in the management of these patients.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Bhatia, Neal

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Dermatologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen

Inhaltsverzeichnis

Introduction.- Mechanisms of Action: Targets for Immunomodulators.- Steroid and Non-Steroid Immunomodulators.- Biologics as Immunomodulators.- Combinations of topical and systemic Immunomodulators,- Nanotechnology and Immunomodulators.- Antibiotics and Antimicrobials as Immunomodulators.- Integrative Therapies as Immunomodulators.- Immunomodulators and Biologics for Follicular and Neutrophilic Cutaneous Disorders.- Immunomodulators for Common Dermatologic Disorders.- Prescribing and Advocating for Immunomodulators in Dermatology Practice.- Conclusion.

Über Autor(innen)

Dr. Neal Bhatia is a leading dermatologist in Southern California with extensive experience in treating a wide range of common and rare dermatological diseases.  After earning dual bachelor of science degrees in bacteriology and genetics from the University of Wisconsin, Dr. Bhatia completed his medical degree at the University of Wisconsin School of Medicine before completing residencies in internal medicine and dermatology at Medical College of Wisconsin in Milwaukee.  He serves as Director of Clinical Dermatology at Therapeutics Clinical Research and is Chief Medical Editor for the journal .  He has a background in immunology and has interests in mechanisms of therapy, skin cancer, and medical dermatology.  He has been involved in countless clinical trials as well.  Dr. Bhatia has served on the AAD Board of Directors as well as Vice President of the AAD in 2021, and he maintains memberships in several other professional organizations.